Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis

Area of Science:

• Rheumatology
• Molecular Biology
• Cellular Signaling

Background:

• Rheumatoid arthritis (RA) involves chronic inflammation.
• Signal Transducer and Activator of Transcription 3 (STAT3) plays a role in inflammatory pathways.

Purpose of the Study:

• To investigate the impact of hypoxia on STAT3-driven pro-inflammatory pathways in RA.
• To explore the interplay between hypoxia-inducible factor 1-alpha (HIF1α), STAT3, and Notch-1 signaling in RA pathogenesis.

Main Methods:

• Assessed phospho-STAT3 in RA synovial tissue and fibroblasts.
• Utilized cell cultures under hypoxic/normoxic conditions with siRNA or JAK2 inhibitor (WP1066).
• Quantified protein expression (HIF1α, p-STAT3, p-STAT1, Notch-1IC), cell functions (invasion, migration), and cytokine/MMP levels (ELISA, real-time PCR).

Main Results:

• Hypoxia increased p-STAT3, p-STAT1, and HIF1α in RA cells; this was blocked by Stat3-siRNA and WP1066.
• Hypoxia-induced cell invasion, migration, and cytokine release were reduced by Stat3-siRNA and WP1066.
• WP1066 inhibited hypoxia-induced Notch-1 signaling and, ex vivo, reduced pro-inflammatory cytokine and MMP3 secretion while increasing IL-10.

Conclusions:

• Established a functional link between HIF1α, STAT3, and Notch-1 signaling in RA inflammation.
• Demonstrated that STAT3 blockade (e.g., with WP1066) is a potential therapeutic strategy for RA.